[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01GA01, streptomycin, Ganciclovir may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01CG01, sulbactam, Ganciclovir may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Sulfamethoxazole.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AX03, sulthiame, The therapeutic efficacy of Sulthiame can be decreased when used in combination with Ganciclovir.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Ganciclovir.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Ganciclovir.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Ganciclovir may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Ganciclovir.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Thiamine.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05CA19, thiopental, The therapeutic efficacy of Thiopental can be decreased when used in combination with Ganciclovir.]
[G04BE06, moxisylyte, Ganciclovir may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Ganciclovir may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01AA12, tobramycin, Ganciclovir may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[V04CA01, tolbutamide, Ganciclovir may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triamcinolone is combined with Ganciclovir.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Ganciclovir.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Ganciclovir may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Ganciclovir.]
[A03AA05, trimebutine, Ganciclovir may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[N03AC02, trimethadione, The therapeutic efficacy of Trimethadione can be decreased when used in combination with Ganciclovir.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Ganciclovir.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Tubocurarine.]
[R03DX07, roflumilast, Ganciclovir may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Ganciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[R02AA14, oxyquinoline, Ganciclovir may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The risk or severity of adverse effects can be increased when Linagliptin is combined with Ganciclovir.]
[S01AA28, vancomycin, Ganciclovir may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, The therapeutic efficacy of Ezogabine can be decreased when used in combination with Ganciclovir.]
[B01AF01, rivaroxaban, Ganciclovir may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[C08DA01, verapamil, The excretion of Ganciclovir can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, Ganciclovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.]
[L01CA02, vincristine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Ganciclovir.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[B01AA03, warfarin, Ganciclovir may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[S01AA13, fusidic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Fusidic acid.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Ganciclovir.]
[J05AE02, indinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Ganciclovir.]
[N03AX14, levetiracetam, The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Ganciclovir.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Ganciclovir.]
[M05BA05, tiludronic acid, Ganciclovir may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Ganciclovir may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[A02BC04, rabeprazole, Ganciclovir may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Ganciclovir.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Ganciclovir may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Ganciclovir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, Ganciclovir may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Ganciclovir.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[B03XA04, peginesatide, Ganciclovir may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ganciclovir.]
[J07BK01, varicella-zoster virus vaccine live (Oka-Merck) strain, The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Ganciclovir.]
[A08AA11, lorcaserin, Ganciclovir may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Ganciclovir may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[L02BB04, enzalutamide, Ganciclovir may decrease the excretion rate of Enzalutamide which could result in a higher serum level.]
[N05CA04, barbital, The therapeutic efficacy of Barbital can be decreased when used in combination with Ganciclovir.]
[D02BA02, octinoxate, Ganciclovir may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The risk or severity of adverse effects can be increased when Nelfinavir is combined with Ganciclovir.]
[N04BD02, rasagiline, Ganciclovir may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Ganciclovir.]
[N03AX22, perampanel, The therapeutic efficacy of Perampanel can be decreased when used in combination with Ganciclovir.]
[V09IX04, fluorodeoxyglucose F18, Ganciclovir may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Ganciclovir.]
[V08CA11, gadofosveset, Ganciclovir may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[A16AX08, teduglutide, Ganciclovir may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[A10BH04, alogliptin, Ganciclovir may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Ganciclovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Ganciclovir may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AA12, ancestim, Ganciclovir may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01EE01, trametinib, Ganciclovir may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Ganciclovir may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Ganciclovir may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[A10BJ03, lixisenatide, Ganciclovir may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Ganciclovir.]
[C02KX04, macitentan, Ganciclovir may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Ganciclovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AF04, eslicarbazepine, The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Ganciclovir.]
[J05AP08, sofosbuvir, Ganciclovir may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[N03AG04, vigabatrin, The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Ganciclovir.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Ganciclovir may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, Ganciclovir may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[L04AA32, apremilast, Ganciclovir may decrease the excretion rate of Apremilast which could result in a higher serum level.]
[L02BG02, formestane, Ganciclovir may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Ganciclovir.]
[V03AB34, fomepizole, Ganciclovir may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Bezafibrate.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S03AA06, gentamicin, Ganciclovir may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AF03, edoxaban, Ganciclovir may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[L01EF01, palbociclib, The risk or severity of adverse effects can be increased when Palbociclib is combined with Ganciclovir.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A07DA06, eluxadoline, The excretion of Eluxadoline can be decreased when combined with Ganciclovir.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Acipimox.]
[V03AB37, idarucizumab, Ganciclovir may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Trabectedin.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Ganciclovir.]
[L01XG03, ixazomib, Ganciclovir may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[M04AB05, lesinurad, Ganciclovir may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AX23, brivaracetam, The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Ganciclovir.]
[N05BA08, bromazepam, Ganciclovir may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Ganciclovir may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Ganciclovir.]
[N01BB01, bupivacaine, Levobupivacaine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Ganciclovir may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Ganciclovir may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A06AH05, naldemedine, Ganciclovir may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Ganciclovir may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, The therapeutic efficacy of Pregabalin can be decreased when used in combination with Ganciclovir.]
[N03AX30, beclamide, The therapeutic efficacy of Beclamide can be decreased when used in combination with Ganciclovir.]
[P01CA02, benznidazole, Ganciclovir may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Abacavir.]
[N07XX13, valbenazine, Ganciclovir may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ganciclovir.]
[L01ED04, brigatinib, The excretion of Ganciclovir can be decreased when combined with Brigatinib.]
[J01MA23, delafloxacin, Ganciclovir may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Acetylcholine.]
[L01BC06, capecitabine, Ganciclovir may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01EM02, copanlisib, The excretion of Ganciclovir can be decreased when combined with Copanlisib.]
[L01EF03, abemaciclib, The excretion of Abemaciclib can be decreased when combined with Ganciclovir.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J05AG03, efavirenz, The risk or severity of adverse effects can be increased when Efavirenz is combined with Ganciclovir.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Ganciclovir may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Ganciclovir may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Ganciclovir.]
[L02BB05, apalutamide, The excretion of Ganciclovir can be decreased when combined with Apalutamide.]
[N03AF01, carbamazepine, Ganciclovir may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Ganciclovir.]
[N03AX24, cannabidiol, The therapeutic efficacy of Cannabidiol can be decreased when used in combination with Ganciclovir.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Ganciclovir.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Ganciclovir.]
[J01GB14, plazomicin, Ganciclovir may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[P01BA07, tafenoquine, The excretion of Ganciclovir can be decreased when combined with Tafenoquine.]
[A16AX14, migalastat, Ganciclovir may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The therapeutic efficacy of Stiripentol can be decreased when used in combination with Ganciclovir.]
[L01EB07, dacomitinib, The risk or severity of adverse effects can be increased when Dacomitinib is combined with Ganciclovir.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[D08AE05, chloroxylenol, Ganciclovir may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01EX13, gilteritinib, The risk or severity of adverse effects can be increased when Gilteritinib is combined with Ganciclovir.]
[L01XJ03, glasdegib, The excretion of Ganciclovir can be decreased when combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Ganciclovir is combined with Amifampridine.]
[A06AX05, prucalopride, Ganciclovir may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, Ganciclovir may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Ciprofibrate.]
[N06BA14, solriamfetol, Ganciclovir may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N06AX29, brexanolone, The therapeutic efficacy of Brexanolone can be decreased when used in combination with Ganciclovir.]
[N05BA09, clobazam, The therapeutic efficacy of Clobazam can be decreased when used in combination with Ganciclovir.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Ubidecarenone.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Ganciclovir.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Ganciclovir.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01EX15, pexidartinib, The excretion of Ganciclovir can be decreased when combined with Pexidartinib.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DC07, cefotiam, The excretion of Cefotiam can be decreased when combined with Ganciclovir.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Ganciclovir.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01EJ02, fedratinib, The excretion of Ganciclovir can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The risk or severity of adverse effects can be increased when Pitolisant is combined with Ganciclovir.]
[N04CX01, istradefylline, The excretion of Ganciclovir can be decreased when combined with Istradefylline.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Ganciclovir.]
[J01DB01, cephalexin, The excretion of Cephalexin can be decreased when combined with Ganciclovir.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Ganciclovir.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AX25, cenobamate, The therapeutic efficacy of Cenobamate can be decreased when used in combination with Ganciclovir.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M09AX08, golodirsen, Ganciclovir may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Ganciclovir may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01XX72, tazemetostat, The excretion of Ganciclovir can be decreased when combined with Tazemetostat.]
[J05AB16, remdesivir, The excretion of Ganciclovir can be decreased when combined with Remdesivir.]
[R02AA03, dichlorobenzyl alcohol, Ganciclovir may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Ganciclovir may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C08CA16, clevidipine, Ganciclovir may decrease the excretion rate of Clevidipine which could result in a higher serum level.]
[C01BD07, dronedarone, The risk or severity of adverse effects can be increased when Dronedarone is combined with Ganciclovir.]
[N03AG02, dipropylacetamide, The therapeutic efficacy of Valpromide can be decreased when used in combination with Ganciclovir.]
[L01EH03, tucatinib, The excretion of Ganciclovir can be decreased when combined with Tucatinib.]
[L01EX17, capmatinib, The excretion of Ganciclovir can be decreased when combined with Capmatinib.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01EX19, ripretinib, The excretion of Ganciclovir can be decreased when combined with Ripretinib.]
[V08CA05, mangafodipir, Ganciclovir may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, The excretion of Ganciclovir can be decreased when combined with Selpercatinib.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05CM02, chlormethiazole, The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Ganciclovir.]
[M09AX10, risdiplam, The serum concentration of Ganciclovir can be increased when it is combined with Risdiplam.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Ganciclovir.]
[L01EX23, pralsetinib, The excretion of Ganciclovir can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Ganciclovir.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N02BA03, choline salicylate, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Choline salicylate.]
[N06BX18, vinpocetine, The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Ganciclovir.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Etofibrate.]
[M01AX25, chondroitin sulfates, Ganciclovir may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[V03AF12, trilaciclib, The excretion of Ganciclovir can be decreased when combined with Trilaciclib.]
[N03AX10, felbamate, The therapeutic efficacy of Felbamate can be decreased when used in combination with Ganciclovir.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Ganciclovir.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Ganciclovir.]
[N02BG07, flupirtine, Ganciclovir may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The risk or severity of adverse effects can be increased when Formoterol is combined with Ganciclovir.]
[A02BA01, cimetidine, The excretion of Cimetidine can be decreased when combined with Ganciclovir.]
[N02BF01, gabapentin, The therapeutic efficacy of Gabapentin can be decreased when used in combination with Ganciclovir.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S03AA07, ciprofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Ganciclovir.]
[L01XA01, cisplatin, Ganciclovir may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The excretion of Ganciclovir can be decreased when combined with Fexinidazole.]
[V09AB03, ioflupane I-123, Ganciclovir may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Ganciclovir may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Ganciclovir may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[J05AX10, maribavir, The therapeutic efficacy of Ganciclovir can be decreased when used in combination with Maribavir.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Clofibrate is combined with Ganciclovir.]
[N01BB10, levobupivacaine, Levobupivacaine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01EJ03, pacritinib, The serum concentration of Ganciclovir can be increased when it is combined with Pacritinib.]
[N06AA04, clomipramine, Ganciclovir may decrease the excretion rate of Clomipramine which could result in a higher serum level.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be decreased when used in combination with Ganciclovir.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Ganciclovir.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Clozapine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01GB12, arbekacin, Ganciclovir may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Codeine is combined with Ganciclovir.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Colchicine.]
[J01XB01, colistin, Ganciclovir may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Leflunomide.]
[A04AA03, tropisetron, Ganciclovir may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Ganciclovir.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J05AB14, valganciclovir, Ganciclovir may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[J05AF09, emtricitabine, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Emtricitabine.]
[C05BB03, invert sugar, Ganciclovir may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Ganciclovir may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Ganciclovir may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Ganciclovir may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Ganciclovir may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Ganciclovir.]
[N05BA10, ketazolam, Ganciclovir may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01EA01, imatinib, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Imatinib.]
[N03AX09, lamotrigine, The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Ganciclovir.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Ganciclovir.]
[N07BC04, lofexidine, Ganciclovir may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Ganciclovir may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Mebeverine.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Ganciclovir may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, The excretion of Tenofovir disoproxil can be decreased when combined with Ganciclovir.]
[S01XA18, cyclosporine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Ganciclovir.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Ganciclovir.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Ganciclovir.]
[J05AF10, entecavir, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Entecavir.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N07BB05, nalmefene, Ganciclovir may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N06AX06, nefazodone, Ganciclovir may decrease the excretion rate of Nefazodone which could result in a higher serum level.]
[C01DX16, nicorandil, Ganciclovir may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AG06, tiagabine, The therapeutic efficacy of Tiagabine can be decreased when used in combination with Ganciclovir.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N06AA01, desipramine, The risk or severity of adverse effects can be increased when Desipramine is combined with Ganciclovir.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[V04CH02, indigo carmine, Ganciclovir may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Ganciclovir.]
[S03BA01, dexamethasone, The excretion of Dexamethasone can be decreased when combined with Ganciclovir.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AC01, paramethadione, The therapeutic efficacy of Paramethadione can be decreased when used in combination with Ganciclovir.]
[B01AC04, clopidogrel, The risk or severity of adverse effects can be increased when Clopidogrel is combined with Ganciclovir.]
[P03AC04, permethrin, Ganciclovir may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The therapeutic efficacy of Diazepam can be decreased when used in combination with Ganciclovir.]
[N03AX07, phenacemide, The therapeutic efficacy of Phenacemide can be decreased when used in combination with Ganciclovir.]
[N03AD02, phensuximide, The therapeutic efficacy of Phensuximide can be decreased when used in combination with Ganciclovir.]
[R05DA08, pholcodine, Ganciclovir may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J05AF03, zalcitabine, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Zalcitabine.]
[J05AF02, didanosine, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Didanosine.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[D07XC04, diflucortolone, Ganciclovir may decrease the excretion rate of Difluocortolone which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01AA05, digoxin, Ganciclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[H03BC01, potassium perchlorate, Ganciclovir may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[V03AB09, dimercaprol, Ganciclovir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Ganciclovir may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.]
[N03AG05, progabide, The therapeutic efficacy of Progabide can be decreased when used in combination with Ganciclovir.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Ganciclovir.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Ganciclovir.]
[S01AX06, resorcinol, Ganciclovir may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The risk or severity of adverse effects can be increased when Disopyramide is combined with Ganciclovir.]
[S02AA12, rifamycin SV, The excretion of Ganciclovir can be decreased when combined with Rifamycin.]
[N07XX02, riluzole, The therapeutic efficacy of Riluzole can be decreased when used in combination with Ganciclovir.]
[R06AE09, levocetirizine, Ganciclovir may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01EB18, ranolazine, The excretion of Ganciclovir can be decreased when combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Ganciclovir.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Dopamine.]
[N06AA12, doxepin, Ganciclovir may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A08AA10, sibutramine, Ganciclovir may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Simvastatin is combined with Ganciclovir.]
[A12CA02, sodium sulfate, Ganciclovir may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[V04CX07, edrophonium, Ganciclovir may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Ganciclovir.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Ganciclovir.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Tianeptine.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Ganciclovir.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N06AG03, toloxatone, Ganciclovir may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AX11, topiramate, The therapeutic efficacy of Topiramate can be decreased when used in combination with Ganciclovir.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Ganciclovir may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01EA01, epinephrine, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Epinephrine.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Guanfacine.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Iloprost.]
[N03AG01, valproic acid, The excretion of Valproic acid can be decreased when combined with Ganciclovir.]
[L03AX05, pidotimod, Ganciclovir may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be decreased when used in combination with Ganciclovir.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Ganciclovir.]
[G03CA57, estrogens, conjugated (USP), The excretion of Conjugated estrogens can be decreased when combined with Ganciclovir.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AA04, fluvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AD01, ethosuximide, The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Ganciclovir.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be decreased when used in combination with Ganciclovir.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L04AD02, tacrolimus, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrolimus is combined with Ganciclovir.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Ganciclovir.]
[P01AX07, trimetrexate, Ganciclovir may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Ganciclovir.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Ganciclovir.]
[C10AA03, pravastatin, The excretion of Pravastatin can be decreased when combined with Ganciclovir.]
[B05AA05, dextran, Ganciclovir may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Ganciclovir.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Ganciclovir.]
[N03AX26, fenfluramine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Ganciclovir.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Ganciclovir.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Ganciclovir.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[G04BD02, flavoxate, Ganciclovir may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The excretion of Flecainide can be decreased when combined with Ganciclovir.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J02AX01, flucytosine, Ganciclovir may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Ganciclovir may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The therapeutic efficacy of Flunarizine can be decreased when used in combination with Ganciclovir.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ethanol is combined with Ganciclovir.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01BC03, tegafur, Ganciclovir may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Ganciclovir.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Ganciclovir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Ganciclovir may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[N03AA04, barbexaclone, The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Ganciclovir.]
[C10AB04, gemfibrozil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Gemfibrozil.]
[J01XA03, telavancin, Ganciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[J05AF11, telbivudine, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Telbivudine.]
[N03AD03, methsuximide, The therapeutic efficacy of Methsuximide can be decreased when used in combination with Ganciclovir.]
[A10BB07, glipizide, Ganciclovir may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C02CA04, doxazosin, The risk or severity of adverse effects can be increased when Doxazosin is combined with Ganciclovir.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01CB04, aurothioglucose, Ganciclovir may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Ganciclovir may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01EX01, guanethidine, Ganciclovir may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05AD01, haloperidol, Haloperidol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05AH04, quetiapine, Ganciclovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Ganciclovir may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Ganciclovir.]
[G03DC01, allylestrenol, Ganciclovir may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05CA16, hexobarbital, The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Ganciclovir.]
[J05AG01, nevirapine, The risk or severity of adverse effects can be increased when Nevirapine is combined with Ganciclovir.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C02DB02, hydralazine, Ganciclovir may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Ganciclovir.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Ganciclovir.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Ganciclovir may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[G04BD06, propiverine, Ganciclovir may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Ganciclovir may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Ganciclovir.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[B05XA08, sodium acetate, Ganciclovir may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01AA06, ifosfamide, Ganciclovir may decrease the excretion rate of Ifosfamide which could result in a higher serum level.]
[N06AA02, imipramine, Imipramine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01CD01, paclitaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Paclitaxel.]
[R01AD07, tixocortol, Ganciclovir may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The therapeutic efficacy of Tizanidine can be decreased when used in combination with Ganciclovir.]
[L01CE01, topotecan, The excretion of Topotecan can be decreased when combined with Ganciclovir.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The excretion of Indomethacin can be decreased when combined with Ganciclovir.]
[A11HA07, inositol, Ganciclovir may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, Ganciclovir may decrease the excretion rate of Milnacipran which could result in a higher serum level.]
[S01XA28, varenicline, Ganciclovir may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Ganciclovir.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05CH02, ramelteon, Ramelteon may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AA06, cerivastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cerivastatin is combined with Ganciclovir.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Stavudine.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Ganciclovir.]
[J04AC01, isoniazid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isoniazid is combined with Ganciclovir.]
[J05AX05, inosine pranobex, Ganciclovir may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Ganciclovir.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Ganciclovir.]
[S01AA24, kanamycin, Ganciclovir may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ganciclovir.]
[N01AX03, ketamine, Ganciclovir may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Ganciclovir may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Amantadine is combined with Ganciclovir.]
[A06AX03, lubiprostone, Ganciclovir may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The therapeutic efficacy of Lacosamide can be decreased when used in combination with Ganciclovir.]
[S01AA21, amikacin, Ganciclovir may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA06, lorazepam, The therapeutic efficacy of Lorazepam can be decreased when used in combination with Ganciclovir.]
[C10AA02, lovastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lovastatin is combined with Ganciclovir.]
[B05XA11, magnesium chloride, Ganciclovir may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Ganciclovir may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Ganciclovir.]
[L01BA05, pralatrexate, Ganciclovir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be decreased when used in combination with Ganciclovir.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Ganciclovir.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Ganciclovir may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AB04, mephenytoin, The therapeutic efficacy of Mephenytoin can be decreased when used in combination with Ganciclovir.]
[N03AA01, mephobarbital, The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Ganciclovir.]
[N01BB03, mepivacaine, Mepivacaine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[G04BX16, tiopronin, Ganciclovir may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Ganciclovir may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, The excretion of Ganciclovir can be decreased when combined with Metformin.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N06BA03, methamphetamine, Ganciclovir may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, The risk or severity of cytopenia can be increased when Ganciclovir is combined with Lamivudine.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be decreased when used in combination with Ganciclovir.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01BA04, pemetrexed, Ganciclovir may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, The therapeutic efficacy of Methohexital can be decreased when used in combination with Ganciclovir.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L04AX03, methotrexate, The excretion of Methotrexate can be decreased when combined with Ganciclovir.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methyldopa is combined with Ganciclovir.]
[V04CG05, methylene blue, The excretion of Ganciclovir can be decreased when combined with Methylene blue.]
[N03AF03, rufinamide, The therapeutic efficacy of Rufinamide can be decreased when used in combination with Ganciclovir.]
[G03EK01, methyltestosterone, Ganciclovir may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[V04CD01, metyrapone, Ganciclovir may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Minocycline.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01BD01, amiodarone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Amiodarone.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Ganciclovir may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.]
[G04BA01, ammonium chloride, Ganciclovir may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L04AA06, mycophenolic acid, The serum concentration of Mycophenolic acid can be increased when it is combined with Ganciclovir.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be decreased when used in combination with Ganciclovir.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Raltegravir.]
[N03AB05, fosphenytoin, The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Ganciclovir.]
[C07AA12, nadolol, The excretion of Nadolol can be decreased when combined with Ganciclovir.]
[J01CA04, amoxicillin, Ganciclovir may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[V03AB15, naloxone, Ganciclovir may decrease the excretion rate of Naloxone which could result in a higher serum level.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Ganciclovir.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L01CD02, docetaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Docetaxel.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Letrozole.]
[S03AA01, neomycin, Ganciclovir may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Ganciclovir.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[L03AX16, plerixafor, Ganciclovir may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Ganciclovir may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Ganciclovir may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Ganciclovir.]
[C01CE01, inamrinone, Ganciclovir may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Ganciclovir.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Nicotine is combined with Ganciclovir.]
[C08CA05, nifedipine, Ganciclovir may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Ganciclovir.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05CF03, zaleplon, The therapeutic efficacy of Zaleplon can be decreased when used in combination with Ganciclovir.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Pramipexole.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Norepinephrine.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Norfloxacin.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Ofloxacin.]
[N02AA02, opium, Ganciclovir may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Ganciclovir.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Ganciclovir.]
[M03AC01, pancuronium, The risk or severity of adverse effects can be increased when Ganciclovir is combined with Pancuronium.]
[J04AB30, capreomycin, Ganciclovir may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[N05CC05, paraldehyde, The therapeutic efficacy of Paraldehyde can be decreased when used in combination with Ganciclovir.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[G04BD11, fesoterodine, Ganciclovir may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Ganciclovir may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Ganciclovir.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Ganciclovir.]
[J01CE09, penicillin G procaine, Ganciclovir may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Ganciclovir.]
[L01XX08, pentostatin, Ganciclovir may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A10BA01, phenformin, The risk or severity of adverse effects can be increased when Phenformin is combined with Ganciclovir.]
[N03AA02, phenobarbital, The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Ganciclovir.]
[C04AX02, phenoxybenzamine, The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Ganciclovir.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AB02, phenytoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Ganciclovir.]
[S01AE05, levofloxacin, Ganciclovir may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Ganciclovir.]
[B02BA01, vitamin K1, Ganciclovir may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AA05, atorvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Atorvastatin.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Ganciclovir.]
[J05AE01, saquinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Saquinavir.]
[N06BX03, piracetam, Ganciclovir may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Ganciclovir.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Ganciclovir.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Ganciclovir.]
[J05AE03, ritonavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ritonavir is combined with Ganciclovir.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Ganciclovir.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Pitavastatin.]
[C02CA01, prazosin, The risk or severity of adverse effects can be increased when Prazosin is combined with Ganciclovir.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N03AA03, primidone, The therapeutic efficacy of Primidone can be decreased when used in combination with Ganciclovir.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C01BA02, procainamide, The excretion of Procainamide can be decreased when combined with Ganciclovir.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Fenofibrate.]
[G03DA04, progesterone, The risk or severity of adverse effects can be increased when Progesterone is combined with Ganciclovir.]
[R06AD02, promethazine, Ganciclovir may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Ganciclovir.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propofol is combined with Ganciclovir.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Ganciclovir.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[B01AC09, epoprostenol, Ganciclovir may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Ganciclovir.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Ganciclovir is combined with Dalfampridine.]
[P02CC01, pyrantel, Ganciclovir may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[P01BD01, pyrimethamine, The excretion of Ganciclovir can be decreased when combined with Pyrimethamine.]
[C01BA01, quinidine, Ganciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The risk or severity of adverse effects can be increased when Quinine is combined with Ganciclovir.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Ganciclovir.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Ganciclovir.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[N05CA06, secobarbital, The therapeutic efficacy of Secobarbital can be decreased when used in combination with Ganciclovir.]
[J01GB08, sisomicin, Ganciclovir may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Ganciclovir may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Ganciclovir may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
[C01DA14, isosorbide mononitrate, Ganciclovir may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[H02CA04, levoketoconazole, The excretion of Ganciclovir can be decreased when combined with Levoketoconazole.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.]
